Decent Q1 numbers vitalize Ajanta Pharma

Ajanta Pharma was up 5.63% to Rs 931 at 12:29 IST on the BSE after consolidated net profit rose 8.4% to Rs 114.63 crore on 19.8% rise in net sales to Rs 611.94 crore in Q1 June 2019 over Q1 June 2018.

The result was announced after market hours yesterday, 31 July 2019.

Meanwhile, the S&P BSE Sensex was down by 422.92 points or 1.13% to 37,058.83.

On the BSE, 38000 shares were traded in the counter so far compared with average daily volumes of 3536 shares in the past two weeks. The stock had hit a high of Rs 932.4 and a low of Rs 881.55 so far during the day. The stock hit a 52-week high of Rs 1294.1 on 5 September 2018 and a 52-week low of Rs 840 on 31 July 2019.

 

Earnings before interest tax depreciation and amortization (EBITDA) increased 7% to Rs 168 crore in Q1 June 2019 over Q1 June 2018.

Total exports grew 25% to Rs 404 crore in Q1 June 2019 from Rs 324 crore in Q1 June 2018.

Ajanta Pharma is a specialty pharmaceutical formulation company having branded generic business in India, USA and emerging markets.

Powered by Capital Market - Live News